All Companies

Company Description Statussort icon Initial Date
Somatogen Synthetic hemoglobin products for use in blood transfusion Acquired 1988 View Profile
ChemGenics Pharmaceuticals Genetically directed drug discovery focused on fungal bacterial diseases Acquired 1992 View Profile
<a href="/venture-capital/all-companies/perseptive-biosystems">PerSeptive BioSystems</a> Developer of high-technology purification, analysis and synthesis products Acquired 1991 View Profile
<a href="/venture-capital/all-companies/aveo-pharmaceuticals-inc">AVEO Pharmaceuticals, Inc.</a> Discovering, developing and commercializing cancer therapeutics. Public 2003 View Profile
<a href="/venture-capital/all-companies/agios-pharmaceuticals-inc">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs to treat cancer and inborn errors of metabolism. Public 2007 View Profile
<a href="/venture-capital/all-companies/zalicus">Zalicus</a> Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Public 2002 View Profile
<a href="/venture-capital/all-companies/concert-pharmaceuticals-inc">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. Public 2006 View Profile
<a href="/venture-capital/all-companies/t2-biosystems-inc">T2 Biosystems, Inc.</a> Developing innovative diagnostic products to improve patient health. Public 2006 View Profile
<a href="/venture-capital/all-companies/receptos-inc">Receptos, Inc.</a> Developing therapeutic candidates for the treatment of immune and metabolic diseases. Public 2009 View Profile
<a href="/venture-capital/all-companies/tetraphase-pharmaceuticals-inc">Tetraphase Pharmaceuticals, Inc.</a> Creating novel antibiotics for serious and life-threatening multidrug-resistant (MDR) bacterial infections. Public 2006 View Profile
<a href="/venture-capital/all-companies/adolor-corporation">Adolor Corporation</a> Discovery, development and commercialization of prescription pain management products Public 1996 View Profile
<a href="/venture-capital/all-companies/insmed-incorporated">INSMED, Incorporated</a> Pharmaceuticals for treatment of metabolic diseases and endocrine disorders Public 1996 View Profile
<a href="/venture-capital/all-companies/idexx-laboratories">IDEXX Laboratories</a> Products that enhance the ability of veterinarians to economically provide advanced medical care Public 1991 View Profile
<a href="/venture-capital/all-companies/cytyc">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health Public 1989 View Profile
<a href="/venture-capital/all-companies/antigenics">Antigenics</a> Technology and products to treat cancers, infectious diseases, and autoimmune disorders Public 1994 View Profile
<a href="/venture-capital/all-companies/celera">Celera</a> Sequenced human genome; now focused on therapeutics for cancer and other diseases Public 1998 View Profile
<a href="/venture-capital/all-companies/exact-sciences">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers Public 1995 View Profile
<a href="/venture-capital/all-companies/renovis">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders Public 2000 View Profile
<a href="/venture-capital/all-companies/seres-therapeutics">Seres Therapeutics</a> Developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome. Public 2012 View Profile
<a href="/venture-capital/all-companies/editas-medicine">Editas Medicine</a> Leading genome editing company translating its proprietary technology into novel solutions to treat a broad range of genetically-driven diseases. Public 2013 View Profile